JP4481646B2 - 緑膿菌のポリペプチド - Google Patents

緑膿菌のポリペプチド Download PDF

Info

Publication number
JP4481646B2
JP4481646B2 JP2003544075A JP2003544075A JP4481646B2 JP 4481646 B2 JP4481646 B2 JP 4481646B2 JP 2003544075 A JP2003544075 A JP 2003544075A JP 2003544075 A JP2003544075 A JP 2003544075A JP 4481646 B2 JP4481646 B2 JP 4481646B2
Authority
JP
Japan
Prior art keywords
seq
polypeptide
amino acid
acid sequence
isolated polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003544075A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005524387A5 (enExample
JP2005524387A (ja
Inventor
ナタリー チャーランド
ショシー ハメル
ベルナルド アール． ブロデウル
デニス マーチン
イザベル チャーレボイス
ダイアン ブシエール
Original Assignee
アイディー バイオメディカル コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アイディー バイオメディカル コーポレーション filed Critical アイディー バイオメディカル コーポレーション
Publication of JP2005524387A publication Critical patent/JP2005524387A/ja
Publication of JP2005524387A5 publication Critical patent/JP2005524387A5/ja
Application granted granted Critical
Publication of JP4481646B2 publication Critical patent/JP4481646B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2003544075A 2001-11-13 2002-11-13 緑膿菌のポリペプチド Expired - Fee Related JP4481646B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33122101P 2001-11-13 2001-11-13
PCT/CA2002/001740 WO2003042240A2 (en) 2001-11-13 2002-11-13 Polypeptides of pseudomonas aeruginosa

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010016179A Division JP5636194B2 (ja) 2001-11-13 2010-01-28 緑膿菌のポリペプチド

Publications (3)

Publication Number Publication Date
JP2005524387A JP2005524387A (ja) 2005-08-18
JP2005524387A5 JP2005524387A5 (enExample) 2006-01-05
JP4481646B2 true JP4481646B2 (ja) 2010-06-16

Family

ID=23293077

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003544075A Expired - Fee Related JP4481646B2 (ja) 2001-11-13 2002-11-13 緑膿菌のポリペプチド
JP2010016179A Expired - Fee Related JP5636194B2 (ja) 2001-11-13 2010-01-28 緑膿菌のポリペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010016179A Expired - Fee Related JP5636194B2 (ja) 2001-11-13 2010-01-28 緑膿菌のポリペプチド

Country Status (7)

Country Link
US (1) US7459165B2 (enExample)
EP (1) EP1458752A2 (enExample)
JP (2) JP4481646B2 (enExample)
AU (2) AU2002340683C1 (enExample)
CA (2) CA2784450C (enExample)
ES (1) ES2431318T3 (enExample)
WO (1) WO2003042240A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090208535A1 (en) * 2004-06-28 2009-08-20 Proteome Systems Intellectual Property Pty Ltd Novel Methods of Diagnosis of Treatment of P. Aeruginosa Infection and Reagents Therefor
WO2006086330A2 (en) * 2005-02-08 2006-08-17 Id Biomedical Corporation Of Quebec C.O.B. As Glaxosmithkline Biologicals North America Pharmaceutical compositions
US20100028415A1 (en) * 2005-04-12 2010-02-04 Haynes Barton F Method of Inducing Neutralizing Antibodies to Human Immunodeficiency Virus
US7781166B2 (en) * 2006-03-31 2010-08-24 Marshall University Research Corporation Methods of detecting and controlling mucoid pseudomonas biofilm production
SG189957A1 (en) * 2010-11-05 2013-06-28 Morphotek Inc Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers
BR112013016254A2 (pt) * 2010-12-23 2017-07-11 Intercell Austria Ag agentes oprf/i e seu uso em pacientes hospitalizados e outros
WO2015048635A1 (en) 2013-09-27 2015-04-02 Duke University Mper-liposome conjugates and uses thereof
EP3236995A4 (en) * 2014-12-23 2018-07-18 University of Maryland, Baltimore Muc1 decoy peptides for treatment and prevention of bacterial infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425437A (en) 1979-11-05 1984-01-10 Genentech, Inc. Microbial polypeptide expression vehicle
US4431739A (en) 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US4338397A (en) 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
DE3718591A1 (de) * 1987-06-03 1988-12-15 Behringwerke Ag Aeusseres membranprotein f von pseudomonas aeruginosa
US5591838A (en) * 1993-02-12 1997-01-07 Board Of Regents, The University Of Texas System Detection of conversion to mucoidy in pseudomonas aeruginosa infecting cystic fibrosis patients
ATE190657T1 (de) * 1994-12-16 2000-04-15 Chiron Behring Gmbh & Co Immunogenes hybridprotein oprf-oprl erhältlich aus membranproteinen von pseudomonas aeruginosa
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
WO1999057142A2 (en) 1998-05-06 1999-11-11 The Governors Of The University Of Alberta Vaccine for $i(pseudomonas aeruginosa)
GB9915419D0 (en) * 1999-07-01 1999-09-01 Cortecs Uk Ltd Antigens
GB9928676D0 (en) * 1999-12-03 2000-02-02 Provalis Uk Ltd Pseudomonas aeruginosa antigens
JP4355786B2 (ja) * 2001-01-26 2009-11-04 エムシーダブリユー リサーチ フオンデーシヨン インコーポレーテツド シュードモナスｖ抗原を用いる免疫化のための方法および組成物

Also Published As

Publication number Publication date
WO2003042240A3 (en) 2004-07-01
US7459165B2 (en) 2008-12-02
WO2003042240A2 (en) 2003-05-22
AU2009202507B2 (en) 2011-03-17
CA2466474A1 (en) 2003-05-22
AU2002340683C1 (en) 2009-11-12
US20050107597A1 (en) 2005-05-19
AU2009202507A1 (en) 2009-07-16
JP5636194B2 (ja) 2014-12-03
JP2010166913A (ja) 2010-08-05
CA2466474C (en) 2012-10-09
CA2784450A1 (en) 2003-05-22
CA2784450C (en) 2016-09-13
EP1458752A2 (en) 2004-09-22
AU2009202507C1 (en) 2011-09-15
ES2431318T3 (es) 2013-11-26
JP2005524387A (ja) 2005-08-18
AU2002340683B2 (en) 2009-03-26

Similar Documents

Publication Publication Date Title
JP5636194B2 (ja) 緑膿菌のポリペプチド
JP4864264B2 (ja) クラミジア抗原および対応するｄｎａ断片ならびにその使用
JP4667694B2 (ja) クラミジア抗原および対応するｄｎａ断片ならびにその使用
JP2008533016A (ja) 薬学的リポソーム組成物
EP1105490A1 (en) Nucleic acid molecules encoding inclusion membrane protein c of chlamydia
JP4832646B2 (ja) クラミジア抗原および対応するｄｎａ断片ならびにその使用
AU2002340683A1 (en) Polypeptides of pseudomonas aeruginosa
MXPA01004356A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
EP1790659B1 (en) Polypeptides of pseudomonas aeruginosa
US20040132652A1 (en) Pharmaceutical compositions
AU6359899A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
HK1104827A (en) Polypeptides of pseudomonas aeruginosa
JP4397233B2 (ja) モラクセラ（ブランハメラ）カタラーリスポリペプチド及び対応するｄｎａ断片
JP2008530021A (ja) 医薬組成物
JP4413616B2 (ja) モラクセラ（ブランハメラ）カタルハリスのポリペプチド
MXPA01006663A (es) Antigenos de chlamydia y fragmentos de acido desoxirribonucleico correspondientes y usos de los mismos.
US20030059896A1 (en) Novel chlamydia antigens and corresponding DNA fragments
JP2005508146A (ja) モラクセラ（ブランハメラ）カタラーリス抗原
JP2005514011A6 (ja) モラクセラ（ブランハメラ）カタルハリスのポリペプチド
MXPA01005617A (en) Chlamydia

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051108

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051108

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081009

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090106

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090114

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090204

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090212

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090305

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090401

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090617

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090624

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090730

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090806

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090826

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090930

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100128

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20100209

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100301

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100318

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130326

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130326

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140326

Year of fee payment: 4

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees